À retenir
Across 23 randomized trials with 4566 community-dwelling older adults, tracker-based interventions beat usual care for daily steps (SMD 0.58, 95% CI 0.33-0.83) and physical activity time (SMD 0.28, 95% CI 0.10-0.47) right after the intervention. BMI, body fat and physical function did not improve significantly, and the evidence was rated low to moderate certainty.
Study design
Méta-analyse d’essais
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Activity trackers are widely promoted for keeping older people active, yet it is debated whether they change activity, body composition or physical function. The authors pooled randomized trials to test whether tracker-based interventions work in community-dwelling older adults, and compared them with usual care and with conventional interventions.
Population et méthode
Systematic review and meta-analysis of randomized controlled trials (PROSPERO CRD42024516900). PubMed, Embase, Web of Science and CENTRAL were searched from inception to January 2025. Outcomes were physical activity time, daily steps, sedentary time, BMI, body fat, the timed up and go test and the chair stand test. Subgroups compared usual-care versus conventional-intervention controls, and immediate versus short-term follow-up. The analysis included 23 trials with 4566 participants.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Versus usual care, tracker-based interventions increased physical activity time (SMD 0.28, 95% CI 0.10-0.47; P = .003) and daily steps (SMD 0.58, 95% CI 0.33-0.83; P < .001) immediately after the intervention.
- 2Daily sedentary time did not change significantly (MD -1.56, 95% CI -10.88 to 7.76; P = .74).
- 3Against conventional interventions, trackers were at least as effective but not better. At short-term follow-up versus usual care, only daily steps remained higher (SMD 0.23, 95% CI 0.11-0.36; P < .001).
- 4No significant advantage for BMI (MD 0.40, 95% CI -0.08 to 0.89; P = .11), body fat (MD 0.67, 95% CI -0.54 to 1.87; P = .28) or the timed up and go test (MD 0.14, 95% CI -0.87 to 1.16; P = .78). The chair stand test was borderline (SMD -0.31, 95% CI -0.62 to 0; P = .05).
Limites et incertitude
- 1Certainty of the evidence was low to moderate for most outcomes, which the authors state.
- 2The abstract notes only short-term effects, so it is unclear whether higher step counts last beyond the follow-up periods studied.
- 3Trials used different tracker types, intervention components and control conditions, and the abstract does not describe how much this varied.
- 4Because the review pooled step counts across scales, the SMD shows size relative to variation, not an actual number of extra steps per day.
Mise en perspective
For older adults, wearing a tracker as part of a programme probably leads to more walking in the short run, while it is not shown to change BMI, body fat or physical function. A tracker works best as one part of a plan, since it did not beat conventional programmes. People with health conditions should check activity goals with their clinician.
Vos données
This is directly about step counts and active minutes from a wearable. Set a baseline week on your own device, aim for a modest increase, and compare weekly averages rather than single days. Because the benefit shrank at follow-up, build in a way to keep checking in, such as a standing weekly review.
Comprendre ce type de preuve
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
The global aging population faces great challenges. Wearable activity trackers have emerged as tools to promote physical activity among older adults, potentially improving health outcomes. However, the effectiveness of such interventions on physical activity, body composition, and physical function among community-dwelling older adults remains debated.
Objective
This study conducted a systematic review and meta-analysis to evaluate the impact of wearable activity tracker-based interventions on physical activity, body composition, and physical function among community-dwelling older adults.
Methods
We searched the PubMed, Embase, Web of Science, and CENTRAL databases from inception until January 2025 to identify related randomized controlled trials. The outcomes were focused on physical activity (physical activity time, daily step count, and daily sedentary time); body composition (BMI and body fat); and physical function (timed up and go test and chair stand test). Subgroup analysis by different controls (usual care or conventional interventions) and different follow-ups (immediate or short term) were performed.
Results
In total 23 trials with 4566 participants were eligible for analysis. Compared to usual care, there was lo- to moderate-certainty evidence that the wearable activity tracker-based interventions significantly increased physical activity time (standardized mean difference [SMD]=0.28, 95% CI 0.10-0.47; P=.003) and daily step counts (SMD=0.58, 95% CI 0.33-0.83; P<.001) immediately after intervention, while no significant improvements were observed in daily sedentary time (mean difference [MD]=-1.56, 95% CI -10.88 to 7.76; I^(2)=0%; P=.74). These interventions were at least as effective as conventional interventions but did not show superiority. Compared with usual care, the interventions using wearable activity trackers only demonstrated a notable increase in daily step count over short-term follow-up (SMD=0.23, 95% CI 0.11-0.36; P<.001). As for body composition and physical function, there was low- to moderate-certainty evidence that the wearable activity tracker-based interventions did not have a greater impact on BMI (MD=0.40, 95% CI -0.08 to 0.89; P=.11), body fat (MD=0.67, 95% CI -0.54 to 1.87; P=.28), the timed up and go test (MD=0.14, 95% CI -0.87 to 1.16; P=.78), or the chair stand test (SMD=-0.31, 95% CI -0.62 to 0; P=.05).
Conclusions
This systematic review and meta-analysis indicate that wearable activity tracker-based interventions were effective in enhancing physical activity with low to moderate certainty, but did not significantly impact body composition or physical function, with low to moderate certainty, among community-dwelling older adults, particularly immediately after intervention. This intervention showed a more pronounced impact when compared to usual care, rather than to conventional interventions, with low to moderate certainty. It is important to note that this intervention showed moderate-certainty evidence toward improving daily step count, supporting its sustained impact during short-term follow-up.
Trial registration
PROSPERO CRD42024516900; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024516900.
Sources et attribution
Wearable Activity Tracker-Based Interventions for Physical Activity, Body Composition, and Physical Function Among Community-Dwelling Older Adults: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li R, Li Y, Wang L, Li L, Fu C, Hu D, Wei Q.
Journal of medical Internet research · 2025-04-03
DOI: 10.2196/59507 ↗PubMed · 40179387 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

